Abstract C261: Pharmacokinetics (PK) and pharmacodynamics (PD) of the oral transforming growth factor-beta (TGF-β) receptor I kinase inhibitor LY2157299 monohydrate (LY) in hepatocellular carcinoma (HCC) compared to glioma patients.

2013 ◽  
Author(s):  
Eric Raymond ◽  
Sandrine Faivre ◽  
Armondo Santoro ◽  
Robin K. Kelley ◽  
Robin K. Kelley ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Growth Factor ◽  
Transforming Growth Factor Beta ◽  
Transforming Growth Factor ◽  
Kinase Inhibitor ◽  
Growth Factor Beta ◽  
Β Receptor

scholarly journals Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth

Bone ◽  
2012 ◽  
Vol 50 (3) ◽  
pp. 695-703 ◽  
Author(s):  
Xinhai Wan ◽  
Zhi-Gang Li ◽  
Jonathan M. Yingling ◽  
Jun Yang ◽  
Michael W. Starbuck ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Growth Factor ◽  
Transforming Growth Factor Beta ◽  
Bone Growth ◽  
Transforming Growth Factor ◽  
Kinase Inhibitor ◽  
Growth Factor Beta ◽  
Β Receptor
Sign in / Sign up

Export Citation Format

Share Document